Ganem, N.J., Storchova, Z., and Pellman, D. (2007) . Curr. Opin. Genet. Dev. 17, [157] [158] [159] [160] [161] [162] The target of rapamycin complex 1 (TORC1) is a highly conserved serine/ threonine kinase that in mammals activates cell growth in response to nutrients (amino acids), growth factors (such as insulin and insulin-like growth factor), and cellular energy status (ATP) (for review, see Wullschleger et al., 2006) . Although the signaling cascades leading from growth factors and energy to mTORC1 activation are known, the pathway that leads from amino acids to mTORC1 activation is less clear. Nicklin et al. (2009) now close a gap in our understanding of this pathway by identifying amino acid transporters that act upstream of mTORC1.
Multiple pathways converge on mTORC1, making it a focal point for the control of cell growth. Insulin and other growth factors activate mTORC1 by inhibiting the tuberous sclerosis complex (TSC1-TSC2) downstream of AKT (also known as PKB) (Figure 1 ). TSC1-TSC2 is a GTPase-activating protein (GAP) for the small GTPase Rheb, the direct activator of mTORC1. Conversely, mTORC1 activity is decreased in response to a reduction in ATP levels because of the activation of adenosine monophosphate activated protein kinase (AMPK), which phosphorylates and activates TSC1-TSC2. However, not all pathways for mTORC1 activation go through TSC1-TSC2. AMPK also phosphorylates and inactivates mTORC1 directly. It has also been recently shown that amino acids signal to mTORC1 through heterodimers of Rag GTPases (RagA or B and RagC or D), which deliver mTORC1 to GTPloaded Rheb (Kim et al., 2008; Sancak et al., 2008) .
Amino acid availability, in particular the availability of the essential amino acids leucine and arginine, is required for mTORC1 activation (for review, see Avruch et al., 2008) . The absence of leucine or arginine prevents mTORC1 acti-
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The mammalian target of rapamycin complex 1 (mTORC1), which promotes cell growth, is regulated by specific nutrients such as the amino acid leucine. In this issue, Nicklin et al. (2009) describe a mechanism by which glutamine facilitates the uptake of leucine, leading to mTORC1 activation.
figure 1. mTORc1 Activation by Glutamine-Dependent Leucine Uptake (A) Glutamine (Gln) is transported into cells in a sodium (Na + ) dependent manner through SLC1A5 (green). Glutamine in turn is used to import leucine (Leu) via the antiporter SLC7A5-SLC3A2 (purple). Intracellular leucine is sensed by an unknown factor that activates mammalian TOR complex 1 (mTORC1) through the Rag GTPases or through an unknown pathway. Growth factors activate mTORC1 through the PI3K-PDK1-AKT-TSC1/2-Rheb pathway. mTORC1 is activated in the presence of amino acids, growth factors, and energy (not shown). (B) When cells are starved for glutamine, leucine cannot be transported into cells. As a result, mTORC1 is not activated, even in the presence of growth factors.
Gromley, A., Yeaman, C., Rosa, J., Redick, S., Chen, C.T., Mirabelle, S., Guha, M., Sillibourne, J., and Doxsey, S.J. (2005 vation, and removal of either one causes rapid dephosphorylation of the wellcharacterized mTORC1 substrates S6 kinase (S6K) and the translation inhibitor 4E-BP. As shown in Xenopus oocytes, which lack amino acid transporters, extracellular leucine fails to activate TORC1. However, leucine can activate TORC1 in oocytes expressing system L amino acid transporters or in oocytes where this amino acid is injected directly into the cytoplasm (Christie et al., 2002) . Intriguingly, it has been suggested that glutamine has a secondary but otherwise poorly understood role in the activation of mTORC1 in mammalian cells (Krause et al., 2002) . Despite the importance of particular amino acids in the regulation of cell growth, it has been unclear how leucine enters cells to activate mTORC1 and what role glutamine has in this process.
Using S6K1 and 4E-BP phosphorylation as a readout for mTORC1 activity, Nicklin et al. (2009) show that mTORC1 activation in response to leucine requires preloading of cells with glutamine. Glutamine alone has no effect on mTORC1, but it must be present in cells before external leucine can have any effect on mTORC1. Using pharmacological inhibitors and short-interfering RNAs (siRNAs), the authors demonstrate that glutamine uptake requires SLC1A5, a high-affinity transporter for neutral amino acids that lack branched side chains (Fuchs and Bode, 2005) . If SLC1A5 is inhibited during the incubation of cells with glutamine, subsequent incubation of cells with leucine has no effect on mTORC1 activity. Thus, glutamine is upstream of leucine in the activation of mTORC1. The authors further show that glutamine metabolites, including amino acids synthesized from glutamine, cannot substitute for glutamine in mTORC1 activation, indicating that it is glutamine itself that is required.
How does glutamine act upstream of leucine? The authors show that the transporter that imports leucine to regulate mTORC1 is a heterodimeric system L amino acid transporter called SLC7A5-SLC3A2. Importantly, SLC7A5-SLC3A2 is an antiporter that imports branched amino acids such as leucine while exporting glutamine (Fuchs and Bode, 2005) . Using pharmacological inhibitors and siRNAs, the authors show that inhibition of SLC7A5-SLC3A2 prevents mTORC1 activation by glutamine and leucine without affecting glutamine uptake. Analysis of the composition of tissue culture medium from growing cells, as well as experiments using stable glutamine and leucine isotopes, demonstrates that glutamine is indeed released from glutamine preloaded cells when incubated with leucine. Furthermore, under the authors' experimental conditions, the uptake of leucine correlates with rapid S6K1 phosphorylation. Thus, glutamine acts upstream of leucine as an efflux solute allowing the influx of leucine through the SLC7A5-SLC3A2 antiporter (Figure 1) .
Nicklin et al. also examined the involvement of the glutamine and leucine transporters in physiological processes regulated by mTORC1, in particular cell growth and autophagy. Reduced transport of glutamine or leucine due to knockdown of SLC1A5 or SLC7A5-SLC3A2 expression, respectively, causes a marked reduction in cell size. Knockdown of the expression of SLC1A5 or an absence of glutamine also induces autophagy. Thus, the two transporters appear to be physiologically relevant activators of mTORC1.
Nicklin et al. provide important new insight into the molecular mechanism by which glutamine and leucine signal to mTORC1. However, many questions remain. What are the transporters for the amino acids other than leucine and glutamine that influence mTORC1 activity? Do sequestered intracellular pools of amino acids, such as those in the lysosome, regulate mTORC1 activity and what is the role of intracellular amino acid transporters? mTORC1 activity enhances surface expression of amino acid transporters in response to nutrients (Edinger and Thompson, 2002) . Does a positive feedback loop involving amino acid transporters regulate mTORC1 in a physiologically relevant manner? Importantly, does intracellular leucine activate mTORC1 via the Rag GTPases? What are the intracellular sensors for leucine and other amino acids? Are these sensors specific to each amino acid or are they more general? Lastly, the kinase MAP4K3, the proposed mTORC1 inhibitor FKBP38, and the type III phosphoinositide 3-kinase hVPS34 have also been implicated in the regulation of mTORC1 activity in response to amino acids (Avruch et al., 2008) . What is the relationship between these proteins and SLC7A5-SLC3A2-mediated activation of mTORC1?
These findings may also have implications for cancer. Tumor cells engage in glutamine metabolism exceeding the need for glutamine as a biosynthetic precursor. It has been suggested that glutamine is used to produce NADPH (nicotinamide adenine dinucleotide phosphate) to support anabolic processes necessary for oncogenic growth (DeBerardinis et al., 2007) . Although activation of mTORC1 does not require glutamine metabolism, the results from Nicklin et al. suggest that glutamine could also drive tumor growth through activation of mTORC1.
